As changes in the CD4+ Th-skewing could affect CD8+ T cell functionality, which is pivotal for effective anti-tumor efficacy, we analyzed the effect of AKT-inhibition on CD8+ T cell functionality in presence and absence of CD4+ T cells. The gene discussed is CD4; the disease is neoplasm.